期刊论文[Intralesional therapy using recombinant interferon alpha 2 B in lesions of the uterine cervix caused by human papilloma virus]复制

DOI:复制

文献链接: https://pubmed.ncbi.nlm.nih.gov/2549455复制

其他信息:

PMID: 2549455
作者: A Germano; G Stellato; G Lombardo; A de Simone; G Semenza; ...
摘要: A clinical study on 20 patients with uterine cervix Human Papilloma Virus (HPV) lesions treated with intralesional recombinant alpha 2b interferon (3 millions I.U.) three times a week for three weeks where possible, is presented. After one year from treatment, lesions were cured or stabilized in 18 Patients (90%); progression was observed in 2 patients (10%) for which reason traditional surgical therapy was performed.